Catalyst Wire Dossier Catalyst Wire Dossier

Fuzheng Yangxin Prescription

· Peking University Third Hospital
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fuzheng Yangxin Prescription, covering 2025-05-07 to 2025-05-07. Get the full timeline:

Most recent: Clinical Trial Update: Prospective Cohort Study on Fuzheng Yangxin Prescription For Rapid Rehabilitation of Patients With Qi-Yin Deficiency Syndrome After Coronary Artery Bypass Grafting

See pricing